SEARCH

SEARCH BY CITATION

References

  • Baker, G.R. & Levin, J. (1998) Transient thrombocytopenia produced by administration of macrophage colony-stimulating factor: investigations of the mechanism. Blood, 91, 8999.
  • Bartocci, A., Mastrogiannis, D.S., Migliorati, G., Stockert, R.J., Wolkoff, A.W. & Stanley, E.R. (1987) Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proceedings of the National Academy of Sciences of the United States of America, 84, 61796183.
  • Bukowski, R.M., Budd, G.T., Gibbons, J.A., Bauer, R.J., Childs, A., Antal, J., Finke, J., Tuason, L., Lorenzi, V., McLain, D., Tubbs, R., Edinger, M. & Thomassen, M.J. (1994) Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects. Journal of Clinical Oncology, 12, 97106.
  • Burstein, S.A., Friese, P., Downs, T. & Epstein, R.E. (1991) Canine megakaryocytopoiesis: analysis utilizing a monoclonal antibody to a 140-kd dog platelet protein. Experimental Hematology, 19, 4752.
  • Cobbold, S. & Metcalfe, S. (1994) Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens, 43, 137154.
  • Danilenko, D.M., Rossitto, P.V., Van der Vieren, M., Le Trong, H., McDonough, S.P., Affolter, V.K. & Moore, P.F. (1995) A novel canine leukointegrin, alpha d beta 2, is expressed by specific macrophage subpopulations in tissue and a minor CD8+ lymphocyte subpopulation in peripheral blood. Journal of Immunology, 155, 3544.
  • Francois, B., Trimoreau, F., Vignon, P., Fixe, P., Praloran, V. & Gastinne, H. (1997) Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. American Journal of Medicine, 103, 114120.
  • Heyns, A.D., Lotter, M.G., Kotze, H.F., Pieters, H. & Wessels, P. (1982) Quantification of in vivo distribution of platelets labeled with indium-111 oxine. Journal of Nuclear Medicine, 23, 943944.
  • Hume, D.A., Pavli, P., Donahue, R.E. & Fidler, I.J. (1988) The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. Journal of Immunology, 141, 34053409.
  • Koike, K., Stanley, E.R., Ihle, J.N. & Ogawa, M. (1986) Macrophage colony formation supported by purified CSF-1 and/or interleukin 3 in serum-free culture: evidence for hierarchical difference in macrophage colony-forming cells. Blood, 67, 859864.
  • Lee, S.H., Looareesuwan, S., Chan, J., Wilairatana, P., Vanijanonta, S., Chong, S.M. & Chong, B.H. (1997) Plasma macrophage colony-stimulating factor and P-selectin levels in malaria-associated thrombocytopenia. Thrombosis and Haemostasis, 77, 289293.
  • Lindemann, A., Herrmann, F., Oster, W., Haffner, G., Meyenburg, W., Souza, L.M. & Mertelsmann, R. (1989) Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood, 74, 26442651.
  • Minasian, L.M., Yao, T.J., Steffens, T.A., Scheinberg, D.A., Williams, L., Riedel, E., Houghton, A.N. & Chapman, P.B. (1995) A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma. Cancer, 75, 22512257.
  • Moore, P.F., Rossitto, P.V. & Danilenko, D.M. (1990) Canine leukocyte integrins: characterization of a CD18 homologue. Tissue Antigens, 36, 211220.
  • Motoyoshi, K. (1998) Biological activities and clinical application of M-CSF. International Journal of Hematology, 67, 109122.
  • Munn, D.H., Garnick, M.B. & Cheung, N.K. (1990) Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood, 75, 20422048.
  • Nash, R.A., Burstein, S.A., Storb, R., Yang, W., Abrams, K., Appelbaum, F.R., Boone, T., Deeg, H.J., Durack, L.D., Schuening, F.G., McDonough, S., Moore, P., Nelp, W.B. & Slichter, S. (1995) Thrombocytopenia in dogs induced by granulocyte–macrophage colony-stimulating factor: increased destruction of circulating platelets. Blood, 86, 17651775.
  • Nemunaitis, J., Meyers, J.D., Buckner, C.D., Shannon-Dorcy, K., Mori, M., Shulman, H., Bianco, J.A., Higano, C.S., Groves, E., Storb, R., Hansen, J., Appelbaum, F.R. & Singer, J.W. (1991) Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood, 78, 907913.
  • Paciucci, P.A., Mandeli, J., Oleksowicz, L., Ameglio, F. & Holland, J.F. (1990) Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion. American Journal of Medicine, 89, 308312.
  • Peng, J., Friese, P., Heilmann, E., George, J.N., Burstein, S.A. & Dale, G.L. (1994) Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood, 83, 161166.
  • Peng, J., Friese, P., Wolf, R.F., Harrison, P., Downs, T., Lok, S., Dale, G.L. & Burstein, S.A. (1996) Relative reactivity of platelets from thrombopoietin- and interleukin-6-treated dogs. Blood, 87, 41584163.
  • Rinder, H.M., Bonan, J.L., Rinder, C.S., Ault, K.A. & Smith, B.R. (1991) Dynamics of leukocyte–platelet adhesion in whole blood. Blood, 78, 17301737.
  • Roth, P. & Stanley, E.R. (1992) The biology of CSF-1 and its receptor. Current Topics in Microbiology and Immunology, 181, 141167.
  • Saleh, M.N., Goldman, S.J., LoBuglio, A.F., Beall, A.C., Sabio, H., McCord, M.C., Minasian, L., Alpaugh, R.K., Weiner, L.M. & Munn, D.H. (1995) CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood, 85, 29102917.
  • Sanda, M.G., Yang, J.C., Topalian, S.L., Groves, E.S., Childs, A., Belfort, Jr, R., De Smet, M.D., Schwartzentruber, D.J., White, D.E., Lotze, M.T. & Rosenberg, S.A. (1992) Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study. Journal of Clinical Oncology, 10, 16431649.
  • Schuening, F.G., Appelbaum, F.R., Deeg, H.J., Sullivan-Pepe, M., Graham, T.C., Hackman, R., Zsebo, K.M. & Storb, R. (1993) Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood, 81, 2026.
  • Slichter, S.J. & Bean, M.A. (1991) Tolerance induction and prevention of platelet (PLT) refractoriness in a dog transfusion model: effects of UV-B irradiation with or without WBC depletion. Blood, 78, 389a.
  • Snyder, E.L., Moroff, G., Simon, T. & Heaton, A. (1986) Recommended methods for conducting radiolabeled platelet survival studies. Transfusion, 26, 3742.
  • Weiden, P.L., Storb, R., Slichter, S., Warren, R.P. & Sale, G.E. (1976) Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum. Journal of Immunology, 117, 143150.
  • Yong, K., Salooja, N., Donahue, R.E., Hegde, U. & Linch, D.C. (1992) Human macrophage colony-stimulating factor levels are elevated in pregnancy and in immune thrombocytopenia. Blood, 80, 28972902.